Pfizer Inc (PFE)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 21,905,000 | 24,588,000 | 28,616,000 | 26,813,000 | 28,479,000 | 29,535,000 | 24,995,000 | 30,824,000 | 34,761,000 | 34,849,000 | 38,759,000 | 36,742,000 | 30,969,000 | 24,152,000 | 16,708,000 | 11,940,000 | 10,107,000 | 9,796,000 | 9,869,000 | 10,164,000 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $21,905,000K ÷ $—K
= —
The payables turnover ratio for Pfizer Inc for the period from March 31, 2020, to December 31, 2024, is not available as the data provided indicates that the payables turnover figure is not reported or unavailable.
The payables turnover ratio is a liquidity metric that measures how efficiently a company manages its accounts payable. A higher payables turnover ratio indicates that the company is paying its suppliers more frequently, which could suggest good liquidity and efficient management of working capital. On the other hand, a lower ratio may indicate that the company is taking longer to pay its suppliers, which could signal liquidity issues or a less efficient use of working capital.
Unfortunately, without the specific values for the payables turnover ratio for Pfizer Inc, we are unable to provide a detailed analysis or insight into the company's payables management during the referenced period.
Peer comparison
Dec 31, 2024